Medication info

Etimib 10 mg (Ezetimibe)

Prescription medicationTabletExpired
Ingredient · strength
Ezetimibe›10mg / 1 tablet
Manufacturer / importer
Seongwon Adcock Pharmaceuticals Co., Ltd.
Appearance
White to almost white oblong tablets
Packaging
30 tablets (10 tablets/PTP x3)
Approval status
Expired

MFDS item code 201902792 · Approved 2019.04.30

This product's status changed to Expired on 2024.04.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of hypercholesterolemia, mixed hyperlipidemia, and sitosterolemia
Who uses it
Adults
Adult dosage
A standard cholesterol-lowering diet should be continued while taking this medicine. The recommended dose of this medicine is 10 mg once daily, with or without food. When administered in combination with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), start this medicine in combination with the recommended initial dose of the HMG-CoA reductase inhibitor. If the patient is already receiving a high dose of an HMG-CoA reductase inhibitor, administer this medicine in combination while maintaining the dose of the HMG-CoA reductase inhibitor. When this medicine is administered in combination with fenofibrate (in patients with mixed hyperlipidemia), administer with fenofibrate 160mg once daily or 200mg once daily (see Precautions for Use, 4. General Precautions). 1. Administration to patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use, 2. Patients Requiring Caution). 2. Administration to patients with renal failure No dose adjustment is required in patients with renal failure. 3. Administration to elderly patients No dose adjustment is required when administered to elderly patients. 4. Concomitant administration with bile acid sequestrants This medicine should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant (see Precautions for Use, 5. Interactions).

Ingredients

Manufacturer
Seongwon Adcock Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of hypercholesterolemia, mixed hyperlipidemia, and sitosterolemia

  • Primary hypercholesterolemia
  • elevated total cholesterol
  • elevated low-density lipoprotein cholesterol
  • elevated apolipoprotein B
  • mixed hyperlipidemia
  • elevated non-high-density lipoprotein cholesterol
  • homozygous familial hypercholesterolemia
  • elevated sitosterol
  • elevated campesterol
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia
View approved original text

This medicine is used as an adjunct to diet for the reduction of total cholesterol, low-density lipoprotein cholesterol (LDL-C), and apolipoprotein B in patients with primary hypercholesterolemia and mixed hyperlipidemia. Additionally, it is administered as an adjunct to other lipid-lowering therapies in patients with homozygous familial hypercholesterolemia or, if necessary, in combination with statins. It is also used in conjunction with dietary therapy to reduce sitosterol and campesterol in patients with homozygous sitosterolemia. This medication is indicated when the response to appropriate dietary therapy and non-pharmacological measures is inadequate, and should be used after thoroughly examining the patient's lipid state and excluding secondary causes. It aims to reduce the risk of vascular disease due to hypercholesterolemia and related dyslipidemia, and to improve blood lipid levels.

Dosage and Administration

Adult dosage

A standard cholesterol-lowering diet should be continued while taking this medicine. The recommended dose of this medicine is 10 mg once daily, with or without food. When administered in combination with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), start this medicine in combination with the recommended initial dose of the HMG-CoA reductase inhibitor. If the patient is already receiving a high dose of an HMG-CoA reductase inhibitor, administer this medicine in combination while maintaining the dose of the HMG-CoA reductase inhibitor. When this medicine is administered in combination with fenofibrate (in patients with mixed hyperlipidemia), administer with fenofibrate 160mg once daily or 200mg once daily (see Precautions for Use, 4. General Precautions). 1. Administration to patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use, 2. Patients Requiring Caution). 2. Administration to patients with renal failure No dose adjustment is required in patients with renal failure. 3. Administration to elderly patients No dose adjustment is required when administered to elderly patients. 4. Concomitant administration with bile acid sequestrants This medicine should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant (see Precautions for Use, 5. Interactions).

Precautions

This medication should not be used in patients who are allergic to specific ingredients. In patients with active liver disease or persistent unexplained elevation of liver enzymes, this medication should not be used in conjunction with certain types of cholesterol-lowering agents. Pregnant or nursing women are prohibited from taking this medication with certain cholesterol-lowering agents, so special caution is required for women of childbearing potential. This medication should not be used with certain fibrate medications in patients with severe liver dysfunction or gallbladder disease, and patients with severe renal impairment should also avoid this combination. This medication contains lactose; therefore, patients with lactose intolerance or certain genetic metabolic disorders should avoid its use. Patients with moderate to severe liver impairment may experience increased exposure to this medication, which may lead to unexpected side effects, requiring caution. This medication is generally well-tolerated, but side effects such as headache, abdominal pain, diarrhea, fatigue, muscle pain, and cough may occur. In particular, when used with other cholesterol-lowering agents, liver enzyme elevation or muscle-related adverse reactions may occur more frequently; therefore, regular monitoring is necessary. If muscle pain or weakness is felt, contact a doctor immediately, and discontinue medication if necessary. Since this medication is primarily metabolized in the liver, liver function tests should be conducted regularly, and its use should be re-evaluated if liver function worsens. Patients with severe renal impairment can use this medication, but it is important to periodically check renal function status. There may be drug interactions with other medications, so patients taking anticoagulants, immunosuppressants, bile acid sequestrants, etc., should consult with their doctor or pharmacist. Consultation with a doctor is also necessary before using this medication during pregnancy; its use is not recommended while breastfeeding. The use of this medication is not recommended for children under the age of 6, while pediatric patients aged 6 and older demonstrate a safety profile similar to that of adults. Elderly patients can generally use this medication safely, but caution is required as some may be more sensitive to the drug. This medication should be stored out of reach of children and should not be transferred to another container. In case of overdose, since there is no specific antidote, it is important to receive treatment based on the symptoms.

Side effects

  • Fatigue
  • abdominal pain
  • diarrhea
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • chest pain
Show 58 more
  • dizziness
  • headache
  • constipation
  • bloating
  • nausea
  • increased AST
  • increased ALT
  • myalgia
  • myopathy
  • rhabdomyolysis
  • hepatitis
  • thrombocytopenia
  • vomiting
  • pancreatitis
  • sensory disturbances
  • depression
  • cholelithiasis
  • cholecystitis
  • chest discomfort
  • chest malaise
  • edema
  • asthenia
  • generalized edema
  • diabetic neuropathy
  • tremors
  • epigastric pain
  • vomiting
  • gastritis
  • dry mouth
  • epigastric discomfort
  • belching
  • gastrointestinal disturbances
  • gastroesophageal reflux disease
  • tongue disorders
  • palpitations
  • congestive heart failure
  • myocardial ischemia
  • flushing
  • sputum
  • nasal discharge
  • limb pain
  • diabetes
  • hypoglycemia
  • anemia
  • splenomegaly
  • urticaria
  • hyperhidrosis
  • rash
  • pruritus
  • upper respiratory infection
  • conjunctival injection
  • renal failure
  • abnormal liver function
  • increased serum creatinine
  • increased blood pressure
  • elevated blood urea
  • increased serum creatine phosphokinase
  • abnormal liver function tests

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture; therefore, it should be stored in a tightly sealed container. The storage temperature should be maintained between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

White to almost white oblong tablets

Package unit

30 tablets (10 tablets/PTP x3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.